Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 32

1.

Depression and coronary heart disease: 2018 ESC position paper of the working group of coronary pathophysiology and microcirculation developed under the auspices of the ESC Committee for Practice Guidelines.

Vaccarino V, Badimon L, Bremner JD, Cenko E, Cubedo J, Dorobantu M, Duncker DJ, Koller A, Manfrini O, Milicic D, Padro T, Pries AR, Quyyumi AA, Tousoulis D, Trifunovic D, Vasiljevic Z, de Wit C, Bugiardini R; ESC Scientific Document Group Reviewers .

Eur Heart J. 2019 Jan 28. doi: 10.1093/eurheartj/ehy913. [Epub ahead of print] No abstract available.

PMID:
30698764
2.

Effects of a Carob-Pod-Derived Sweetener on Glucose Metabolism.

Lambert C, Cubedo J, Padró T, Vilahur G, López-Bernal S, Rocha M, Hernández-Mijares A, Badimon L.

Nutrients. 2018 Feb 27;10(3). pii: E271. doi: 10.3390/nu10030271.

3.

Position paper of the European Society of Cardiology-working group of coronary pathophysiology and microcirculation: obesity and heart disease.

Badimon L, Bugiardini R, Cenko E, Cubedo J, Dorobantu M, Duncker DJ, Estruch R, Milicic D, Tousoulis D, Vasiljevic Z, Vilahur G, de Wit C, Koller A.

Eur Heart J. 2017 Jul 1;38(25):1951-1958. doi: 10.1093/eurheartj/ehx181. No abstract available.

PMID:
28873951
4.

Erythrocyte-heme proteins and STEMI: implications in prognosis.

Cubedo J, Suades R, Padro T, Martin-Yuste V, Sabate-Tenas M, Cinca J, Sans-Rosello J, Sionis A, Badimon L.

Thromb Haemost. 2017 Oct 5;117(10):1970-1980. doi: 10.1160/TH17-05-0314. Epub 2017 Jul 27.

PMID:
28837209
5.

Detrimental Effect of Hypercholesterolemia on High-Density Lipoprotein Particle Remodeling in Pigs.

Padró T, Cubedo J, Camino S, Béjar MT, Ben-Aicha S, Mendieta G, Escolà-Gil JC, Escate R, Gutiérrez M, Casani L, Badimon L, Vilahur G.

J Am Coll Cardiol. 2017 Jul 11;70(2):165-178. doi: 10.1016/j.jacc.2017.05.018.

6.

Protein changes in non-LDL-lipoproteins in familial hypercholesterolemia: implications in cardiovascular disease manifestation and outcome.

Badimon L, Padró T, Cubedo J.

Curr Opin Lipidol. 2017 Oct;28(5):427-433. doi: 10.1097/MOL.0000000000000441. Review.

PMID:
28682808
7.

Molecular signature of coronary stent thrombosis: oxidative stress and innate immunity cells.

Cubedo J, Blasco A, Padro T, Ramaiola I, Juan-Babot O, Goicolea J, Fernández-Díaz JA, Oteo JF, Badimon L.

Thromb Haemost. 2017 Aug 30;117(9):1816-1827. doi: 10.1160/TH17-03-069. Epub 2017 Jun 22.

PMID:
28640320
8.

Phytosterols and Omega 3 Supplementation Exert Novel Regulatory Effects on Metabolic and Inflammatory Pathways: A Proteomic Study.

Lambert C, Cubedo J, Padró T, Sánchez-Hernández J, Antonijoan RM, Perez A, Badimon L.

Nutrients. 2017 Jun 13;9(6). pii: E599. doi: 10.3390/nu9060599.

9.

Inflammation and hemostasis in older octogenarians: implication in 5-year survival.

Cubedo J, Padró T, Formiga F, Ferrer A, Padrós G, Peña E, Badimon L.

Transl Res. 2017 Jul;185:34-46.e9. doi: 10.1016/j.trsl.2017.04.003. Epub 2017 Apr 26.

PMID:
28506697
10.

Adipose tissue depots and inflammation: effects on plasticity and resident mesenchymal stem cell function.

Badimon L, Cubedo J.

Cardiovasc Res. 2017 Jul 1;113(9):1064-1073. doi: 10.1093/cvr/cvx096. Review.

PMID:
28498891
11.

Allogenic adipose-derived stem cell therapy overcomes ischemia-induced microvessel rarefaction in the myocardium: systems biology study.

Vilahur G, Oñate B, Cubedo J, Béjar MT, Arderiu G, Peña E, Casaní L, Gutiérrez M, Capdevila A, Pons-Lladó G, Carreras F, Hidalgo A, Badimon L.

Stem Cell Res Ther. 2017 Mar 9;8(1):52. doi: 10.1186/s13287-017-0509-2.

12.

High density lipoproteins and kidney function: the friend turned foe?

Badimon L, Vilahur G, Cubedo J.

J Thorac Dis. 2016 Nov;8(11):2978-2981. doi: 10.21037/jtd.2016.11.66. No abstract available.

13.

Research update for articles published in EJCI in 2014.

Agra RM, Al-Daghri NM, Badimon L, Bodi V, Carbone F, Chen M, Cubedo J, Dullaart RP, Eiras S, García-Monzón C, Gary T, Gnoni A, González-Rodríguez Á, Gremmel T, Hafner F, Hakala T, Huang B, Ickmans K, Irace C, Kholová I, Kimer N, Kytö V, März W, Miazgowski T, Møller S, Montecucco F, Niccoli G, Nijs J, Ozben S, Ozben T, Papassotiriou I, Papastamataki M, Reina-Couto M, Rios-Navarro C, Ritsch A, Sabico S, Seetho IW, Severino A, Sipilä J, Sousa T, Taszarek A, Taurino F, Tietge UJ, Tripolino C, Verloop W, Voskuil M, Wilding JP.

Eur J Clin Invest. 2016 Oct;46(10):880-94. doi: 10.1111/eci.12671. No abstract available.

PMID:
27571922
14.

Pathophysiology of acute coronary syndromes in the elderly.

Badimon L, Bugiardini R, Cubedo J.

Int J Cardiol. 2016 Nov 1;222:1105-1109. doi: 10.1016/j.ijcard.2016.07.205. Epub 2016 Aug 2. Review.

PMID:
27499220
15.

Risk factors' management to impact on acute coronary syndromes.

Badimon L, Cubedo J.

Int J Cardiol. 2016 Aug;217 Suppl:S7-9. doi: 10.1016/j.ijcard.2016.06.216. Epub 2016 Jun 27. No abstract available.

PMID:
27378658
16.

Targeting the molecular mechanisms of ischemic damage: Protective effects of alpha-crystallin-B.

Cubedo J, Vilahur G, Casaní L, Mendieta G, Gómez-Jabalera E, Juan-Babot O, Padró T, Badimon L.

Int J Cardiol. 2016 Jul 15;215:406-16. doi: 10.1016/j.ijcard.2016.04.072. Epub 2016 Apr 16.

PMID:
27128573
17.

ApoL1 levels in high density lipoprotein and cardiovascular event presentation in patients with familial hypercholesterolemia.

Cubedo J, Padró T, Alonso R, Mata P, Badimon L.

J Lipid Res. 2016 Jun;57(6):1059-73. doi: 10.1194/jlr.P061598. Epub 2016 Apr 25.

18.

Hypercoagulability and atrial fibrillation: a two-way road?

Badimon L, Cubedo J.

Eur Heart J. 2017 Jan 1;38(1):51-52. doi: 10.1093/eurheartj/ehw108. Epub 2016 Apr 22. No abstract available.

PMID:
27106954
19.

Hypercholesterolemia Abolishes High-Density Lipoprotein-Related Cardioprotective Effects in the Setting of Myocardial Infarction.

Vilahur G, Gutiérrez M, Casaní L, Cubedo J, Capdevila A, Pons-Llado G, Carreras F, Hidalgo A, Badimon L.

J Am Coll Cardiol. 2015 Dec 1;66(21):2469-2470. doi: 10.1016/j.jacc.2015.08.901. No abstract available.

20.

A novel truncated form of apolipoprotein A-I transported by dense LDL is increased in diabetic patients.

Cubedo J, Padró T, García-Arguinzonis M, Vilahur G, Miñambres I, Pou JM, Ybarra J, Badimon L.

J Lipid Res. 2015 Sep;56(9):1762-73. doi: 10.1194/jlr.P057513. Epub 2015 Jul 13.

Supplemental Content

Loading ...
Support Center